Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $2.64 USD
Change Today +0.03 / 1.15%
Volume 12.8K
GALT On Other Exchanges
As of 11:45 AM 07/29/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

James C. Czirr

Executive Chairman and Executive Vice President - Business Development, Galectin Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 13 board members in 2 different organizations across 4 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. James C. Czirr, also known as Jim served as the Chief Executive Officer of Minerva Biotechnologies Corp. Mr. Czirr served as the President of Extol Energy Corporation, a syndicator of oil and gas wells from 1982 to 1988. He served as an Executive Vice President of Business Development at Pro Pharmaceuticals Inc. (AKA Galectin Therapeutics, Inc.) since May 15, 2001. He was an Independent Corporate and Public Relations Consultant for over ten years, working with various ...

Read Full Background

Corporate Headquarters*

4960 Peachtree Industrial Boulevard
Norcross, Georgia 30071

United States

Phone: 678-620-3186
Fax: 770-864-1327

Board Members Memberships*

Director and Member of Audit Committee
Executive Chairman and Executive Vice President - Business Development


Master's Degree
College For Financial Planning, Inc.
Bachelor's Degree 1976
University of Michigan
Master's Degree
University of Toledo School of Business Administration

Other Affiliations*

Annual Compensation*

Total Annual Compensation$324,000

Stock Options*

All Other Compensation$75,882
Exercisable Options545,898
Exercisable Options Value$278,334
Unexercisable Options181,769
Total Value of Options$278,333
Total Number of Options727,667

Total Compensation*

Total Annual Cash Compensation$399,882
Total Short Term Compensation$324,000
Other Long Term Compensation$75,882
Total Calculated Compensation$1,088,249
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GALT:US $2.64 USD +0.03


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GALECTIN THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at